Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...
Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...
DUBLIN--(BUSINESS WIRE)--The "Good Distribution Practices of Pharmaceuticals and APIs Training Course (Nov 17th - Nov 18th, 2025)" training has been added to ResearchAndMarkets.com's offering. It is ...
Lawmakers are proposing a new effort to strengthen biopharma manufacturing in the U.S., leveraging a bill that seeks to ...
HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent pending drug delivery ...
As the year draws to a close, medium and small drugmakers in India have a deadline coming up in less than two months as the country moves to secure the production of safe and quality medicines. After ...
Key opportunities in the Global Nucleic Acid Therapeutics CDMO Market include leveraging expanding biopharmaceutical R&D ...
Pharmaceutical exports are expected to continue on a healthy trajectory over the next few years with products worth over $250 ...
(MENAFN- GlobeNewsWire - Nasdaq) Emerging market opportunities include enhancing pharmaceutical supply chain integrity through advanced GDP training, tackling counterfeiting risks, boosting cargo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback